Literature DB >> 8541110

Factors affecting recurrence and progression in superficial bladder tumours.

K H Kurth1, L Denis, C Bouffioux, R Sylvester, F M Debruyne, M Pavone-Macaluso, W Oosterlinck.   

Abstract

Prognostic factors in superficial bladder tumours are highly correlated with each other. In this study, their relative importance is examined and grouping of patients in three different prognostic groups suggested. 576 patients (from EORTC protocols 30790 and 30782) were analysed. They have been followed from 3 months to 8.6 years with a median of 4 years. 76 patients developed an invasive tumour (> or = T2); the shortest time to invasion was 12 weeks, the longest was 6.6 years. Time from invasion to death ranged from 3 weeks to 4.4 years with a median of 2 years. Prognostic factors contributing to recurrence, invasion and survival were investigated: age, sex, size of largest tumour, number of tumours, T-category, G-grade, time from diagnosis (years), prior recurrence rate/year, site of involvement. The relative importance of these factors was measured by performing a multivariate analysis based on Cox's proportional hazards regression model. Based on the most important prognostic factors and their association with invasion and death, an index was computed reflecting the risk of both invasion and death due to malignant disease, respectively. The index was used to assign patients to one of three prognostic groups. Three main factors determined patient's prognosis: tumour size, G-grade and prior recurrence rate/year. The model coefficients for invasion were 0.51 (recurrence rate < 1/year, 1-3/year, > 3/year), 84 (grade 1, 2, 3), 0.48 (size < 1.5, 1.5-3, > 3 cm) and for death due to malignant disease 0.89 (recurrence rate), 0.73 (grade) and 0.44 (size), respectively. Risk groups are suggested based on the index. Additional treatment in patients with superficial transitional cell carcinoma of the bladder may be decided depending on the risk group to which the patient belongs.

Entities:  

Mesh:

Year:  1995        PMID: 8541110     DOI: 10.1016/0959-8049(95)00287-s

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  57 in total

Review 1.  Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis. A joint proposal of the European Society of Uropathology and the Uropathology Working Group.

Authors:  Antonio Lopez-Beltran; Pier Francesco Bassi; Michele Pavone-Macaluso; Rodolfo Montironi
Journal:  Virchows Arch       Date:  2004-06-08       Impact factor: 4.064

Review 2.  Defining and treating the spectrum of intermediate risk nonmuscle invasive bladder cancer.

Authors:  Ashish M Kamat; J Alfred Witjes; Maurizio Brausi; Mark Soloway; Donald Lamm; Raj Persad; Roger Buckley; Andreas Böhle; Marc Colombel; Joan Palou
Journal:  J Urol       Date:  2014-03-25       Impact factor: 7.450

Review 3.  Treatment options for BCG failures.

Authors:  Michael A O'Donnell; Andreas Boehle
Journal:  World J Urol       Date:  2006-11       Impact factor: 4.226

4.  [Prediction of tumor recurrence and progression of superficial bladder carcinoma using an artificial neural network].

Authors:  B Planz; T Deix; H P Caspers
Journal:  Urologe A       Date:  2007-09       Impact factor: 0.639

Review 5.  Long-term versus short-term introvesical chemotherapy in patients with non-muscle-invasive bladder cancer: a systematic review and meta-analysis of the published results of randomized clinical trials.

Authors:  Teng Li; Yi Xing; Shu-Cheng Liu; Xiao-Min Han; Wen-Cheng Li; Min Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-10-16

6.  P27(Kip1) and Ki-67 expression analysis in transitional cell carcinoma of the bladder.

Authors:  Bartosz Dybowski; Jolanta Kupryjańczyk; Alina Rembiszewska; Roman Pykało; Andrzej Borkowski
Journal:  Urol Res       Date:  2003-09-27

7.  Long non-coding RNA HNF1A-AS1 promotes cell viability and migration in human bladder cancer.

Authors:  Zhihong Feng; Baolong Wang
Journal:  Oncol Lett       Date:  2018-01-26       Impact factor: 2.967

8.  Correlation of tumor-associated macrophages and NK cells with bladder cancer size and T stage in patients with solitary low-grade urothelial carcinoma.

Authors:  Kristian Krpina; Emina Babarović; Josip Španjol; Gordana Đorđević; Tobias Maurer; Nives Jonjić
Journal:  Wien Klin Wochenschr       Date:  2015-12-11       Impact factor: 1.704

9.  The efficacy of the EORTC scoring system and risk tables for the prediction of recurrence and progression of non-muscle-invasive bladder cancer after intravesical bacillus calmette-guerin instillation.

Authors:  Kyung Won Seo; Byung Hoon Kim; Choal Hee Park; Chun Il Kim; Hyuk Soo Chang
Journal:  Korean J Urol       Date:  2010-03-19

10.  Molecular markers in transitional cell carcinoma of the bladder: New insights into mechanisms and prognosis.

Authors:  Behfar Ehdaie; Dan Theodorescu
Journal:  Indian J Urol       Date:  2008-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.